Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor

Autor: Devineni, Damayanthi, Curtin, Christopher R., Marbury, Thomas C., Smith, William, Vaccaro, Nicole, Wexler, David, Vandebosch, An, Rusch, Sarah, Stieltjes, Hans, Wajs, Ewa
Zdroj: In Clinical Therapeutics 1 March 2015 37(3):610-628
Databáze: ScienceDirect